<DOC>
	<DOCNO>NCT01893814</DOCNO>
	<brief_summary>To demonstrate benefit tolerability probiotic product infant abdominal discomfort .</brief_summary>
	<brief_title>Benefit Tolerability Probiotic Product Infants With Abdominal Discomfort</brief_title>
	<detailed_description />
	<criteria>Male female singleton ≥ 2 week ≤ 12 week age Exclusively breastfed screen Abdominal discomfort ( infant colic ) week prior enrollment , accord statement parent ( ) and/or guardian ( ) Episodes fussy cry last least 3 hour day least 3 day 7 day prior enrollment , accord statement parent ( ) and/or guardian ( ) Voluntary , write informed consent parent ( ) and/or guardian ( ) participate study Born full term ( 3742 last menstruation period ) Birth weight : 2500 4500 g Weightforage ≥ 3th ≤ 97th percentile accord WHO growth table / chart Apparently healthy birth ( Apgar ≥ 8 ) screen visit No major complication pregnancy birth Mother 1945 year age childbirth Ability parent ( ) and/or guardian ( ) attend visit , interview willingness fill questionnaires Intolerance investigational product/its ingredient Severe medical condition illness , congenital abnormality Gastrointestinal disorder ( e.g . reflux esophagitis ) Intake probiotic and/or antibiotic week precede recruitment study Formula feed screening/randomisation Allergy atopic disease ( family history ) Participation another study Mother 's health condition may interfere ability take care infant Mother affect hepatitis B , HIV GuillainBarré Syndrome Use antibiotic mother week</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>